These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 32285484)

  • 21. Identifying Optical Coherence Tomography Markers for Multiple Sclerosis Diagnosis and Management.
    Cujba L; Stan C; Samoila O; Drugan T; Benedec Cutas A; Nicula C
    Diagnostics (Basel); 2023 Jun; 13(12):. PubMed ID: 37370972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis.
    Petzold A; Balcer LJ; Calabresi PA; Costello F; Frohman TC; Frohman EM; Martinez-Lapiscina EH; Green AJ; Kardon R; Outteryck O; Paul F; Schippling S; Vermersch P; Villoslada P; Balk LJ;
    Lancet Neurol; 2017 Oct; 16(10):797-812. PubMed ID: 28920886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.
    Saidha S; Sotirchos ES; Ibrahim MA; Crainiceanu CM; Gelfand JM; Sepah YJ; Ratchford JN; Oh J; Seigo MA; Newsome SD; Balcer LJ; Frohman EM; Green AJ; Nguyen QD; Calabresi PA
    Lancet Neurol; 2012 Nov; 11(11):963-72. PubMed ID: 23041237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance imaging and optical coherence tomography correlations in multiple sclerosis beyond anatomical landmarks.
    Barreiro-González A; Sanz MT; Carratalà-Boscà S; Pérez-Miralles F; Alcalá C; Carreres-Polo J; España-Gregori E; Casanova B
    J Neurol Sci; 2020 Dec; 419():117180. PubMed ID: 33091751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of paramagnetic rim lesions and retinal layer thickness in patients with multiple sclerosis.
    Krajnc N; Dal-Bianco A; Leutmezer F; Kasprian G; Pemp B; Kornek B; Berger T; Rommer PS; Hametner S; Lassmann H; Bsteh G
    Mult Scler; 2023 Mar; 29(3):374-384. PubMed ID: 36537667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis.
    Narayanan D; Cheng H; Bonem KN; Saenz R; Tang RA; Frishman LJ
    Mult Scler; 2014 Sep; 20(10):1331-41. PubMed ID: 24639478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective study of disease modifying therapy and retinal atrophy in relapsing-remitting multiple sclerosis.
    Kabanovski A; Zaslavsky K; Rotstein D; Margolin E
    J Neurol Sci; 2023 Mar; 446():120552. PubMed ID: 36774748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosis.
    Berek K; Hegen H; Hocher J; Auer M; Di Pauli F; Krajnc N; Angermann R; Barket R; Zinganell A; Riedl K; Deisenhammer F; Berger T; Bsteh G
    Mult Scler; 2022 Oct; 28(12):1871-1880. PubMed ID: 35652366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visualization of Focal Thinning of the Ganglion Cell-Inner Plexiform Layer in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    Shao Y; Jiang H; Wei Y; Shi Y; Shi C; Wright CB; Sun X; Vanner EA; Rodriguez AD; Lam BL; Rundek T; Baumel BS; Gameiro GR; Dong C; Wang J
    J Alzheimers Dis; 2018; 64(4):1261-1273. PubMed ID: 30040712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinal thickness as a potential biomarker of neurodegeneration and a predictor of early cognitive impairment in patients with multiple sclerosis.
    Esmael A; Elsherif M; Abdelsalam M; Sabry D; Mamdouh M; Belal T
    Neurol Res; 2020 Jul; 42(7):564-574. PubMed ID: 32370626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripapillary retinal nerve fibre layer thinning rate as a biomarker discriminating stable and progressing relapsing-remitting multiple sclerosis.
    Bsteh G; Hegen H; Teuchner B; Berek K; Wurth S; Auer M; Di Pauli F; Deisenhammer F; Berger T
    Eur J Neurol; 2019 Jun; 26(6):865-871. PubMed ID: 30614590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Racial differences in retinal neurodegeneration as a surrogate marker for cortical atrophy in multiple sclerosis.
    Lichtman-Mikol S; Razmjou S; Yarraguntla K; Bao F; Santiago-Martinez C; Seraji-Bozorgzad N; Bernitsas E
    Mult Scler Relat Disord; 2019 Jun; 31():141-147. PubMed ID: 30991300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of point estimates and average thicknesses of retinal layers measured using manual optical coherence tomography segmentation for quantification of retinal neurodegeneration in multiple sclerosis.
    Sotirchos ES; Seigo MA; Calabresi PA; Saidha S
    Curr Eye Res; 2013 Jan; 38(1):224-8. PubMed ID: 22954302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Stability of Neuroaxonal Structure in Alemtuzumab-Treated Relapsing-Remitting Multiple Sclerosis Patients.
    Chan JK; Hernandez Martínez de Lapiscina E; Taylor C; Nguyen AL; Alba-Arbalat S; Devonshire V; Sayao AL; Carruthers R; Costello F; Traboulsee A
    J Neuroophthalmol; 2020 Mar; 40(1):37-43. PubMed ID: 32045393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease course heterogeneity and OCT in multiple sclerosis.
    Balk LJ; Tewarie P; Killestein J; Polman CH; Uitdehaag B; Petzold A
    Mult Scler; 2014 Aug; 20(9):1198-206. PubMed ID: 24402036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subclinical neurodegeneration in multiple sclerosis and neuromyelitis optica spectrum disorder revealed by optical coherence tomography.
    Pisa M; Ratti F; Vabanesi M; Radaelli M; Guerrieri S; Moiola L; Martinelli V; Comi G; Leocani L
    Mult Scler; 2020 Sep; 26(10):1197-1206. PubMed ID: 31392924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the retinal posterior pole in dominant optic atrophy by spectral-domain optical coherence tomography and microperimetry.
    Cesareo M; Ciuffoletti E; Martucci A; Sebastiani J; Sorge RP; Lamantea E; Garavaglia B; Ricci F; Cusumano A; Nucci C; Brancati F
    PLoS One; 2017; 12(3):e0174560. PubMed ID: 28358911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis.
    Gordon-Lipkin E; Chodkowski B; Reich DS; Smith SA; Pulicken M; Balcer LJ; Frohman EM; Cutter G; Calabresi PA
    Neurology; 2007 Oct; 69(16):1603-9. PubMed ID: 17938370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal optical coherence tomography study of optic atrophy in secondary progressive multiple sclerosis: Results from a clinical trial cohort.
    Winges KM; Murchison CF; Bourdette DN; Spain RI
    Mult Scler; 2019 Jan; 25(1):55-62. PubMed ID: 29111873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical effects associated with five-year retinal nerve fiber layer thinning in multiple sclerosis.
    Jakimovski D; Zivadinov R; Vaughn CB; Ozel O; Weinstock-Guttman B
    J Neurol Sci; 2021 Aug; 427():117552. PubMed ID: 34175775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.